96 studies found for:    70806
Show Display Options
Rank Status Study
1 Recruiting Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany
Condition: Respiratory Syncytial Virus Infections
Intervention:
2 Suspended Vitamin D and Breast Cancer Biomarkers in Female Patients
Condition: Breast Cancer
Interventions: Dietary Supplement: vitamin D;   Other: placebo
3 Active, not recruiting Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Recurrent Renal Cell Cancer;   Stage IV Renal Cell Cancer
Interventions: Drug: sorafenib tosylate;   Drug: temsirolimus;   Biological: bevacizumab;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
4 Active, not recruiting Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Sorafenib and Erlotinib;   Drug: Sorafenib
5 Active, not recruiting A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Extensive-Stage Small Cell Lung Cancer
Interventions: Drug: Amrubicin;   Drug: Carboplatin;   Drug: Pegfilgrastim
6 Unknown  Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: quality-of-life assessment
7 Active, not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: vinorelbine tartrate;   Drug: cisplatin;   Drug: docetaxel;   Drug: pemetrexed disodium;   Biological: bevacizumab;   Other: questionnaire administration;   Other: laboratory biomarker analysis
8 Completed S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin;   Drug: paclitaxel;   Procedure: surgery
9 Completed An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants
Condition: Healthy
Intervention:
10 Completed Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: cisplatin;   Procedure: conventional surgery;   Radiation: radiation therapy
11 Completed
Has Results
Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site
Condition: Neoplasms, Unknown Primary
Interventions: Drug: Oxaliplatin;   Drug: Capecitabine
12 Completed Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
13 Active, not recruiting
Has Results
S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
Condition: Leukemia
Interventions: Drug: gemtuzumab ozogamicin;   Other: observation;   Drug: Cytosine arabinoside;   Drug: Daunomycin
14 Active, not recruiting Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Conditions: Esophageal Cancer;   Gastric Cancer
Interventions: Drug: cisplatin;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Drug: leucovorin calcium;   Radiation: radiation therapy
15 Active, not recruiting S9925: Collecting and Storing Samples From Patients With Lung Cancer
Condition: Lung Cancer
Intervention: Other: biologic sample preservation procedure
16 Active, not recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Male Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: cyclophosphamide;   Drug: paclitaxel;   Biological: bevacizumab;   Other: placebo;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
17 Completed
Has Results
Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
Conditions: Sleep Disorders;   Non-Erosive Reflux Disease;   Gastroesophageal Reflux Disease
Intervention: Drug: Pantoprazole
18 Completed A Study to Describe Pediatric Influenza Vaccine Coverage
Condition: Healthy
Intervention:
19 Recruiting Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions: Anemia;   Renal Insufficiency, Chronic
Interventions: Drug: Molidustat (BAY 85-3934);   Biological: Epoetin alfa/beta
20 Unknown  Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
Condition: Breast Cancer
Interventions: Drug: AC regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years